Sanjeewa Wickremasinghe

3.4k total citations
52 papers, 1.5k citations indexed

About

Sanjeewa Wickremasinghe is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Neurology. According to data from OpenAlex, Sanjeewa Wickremasinghe has authored 52 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Ophthalmology, 38 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Neurology. Recurrent topics in Sanjeewa Wickremasinghe's work include Retinal Diseases and Treatments (40 papers), Retinal Imaging and Analysis (32 papers) and Retinal and Optic Conditions (22 papers). Sanjeewa Wickremasinghe is often cited by papers focused on Retinal Diseases and Treatments (40 papers), Retinal Imaging and Analysis (32 papers) and Retinal and Optic Conditions (22 papers). Sanjeewa Wickremasinghe collaborates with scholars based in Australia, United Kingdom and Singapore. Sanjeewa Wickremasinghe's co-authors include Robyn H. Guymer, Paul N. Baird, Farshad Abedi, Amirul Islam, Sukhpal S. Sandhu, Robert P. Finger, Andrew Osborne, Peter van Wijngaarden, M. A. Whitehead and Keith R. Martin and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Sanjeewa Wickremasinghe

51 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sanjeewa Wickremasinghe Australia 21 1.4k 1.0k 208 183 53 52 1.5k
Alex P. Hunyor Australia 23 1.5k 1.1× 987 1.0× 78 0.4× 167 0.9× 103 1.9× 47 1.6k
Manuel Falcão Portugal 20 1.2k 0.9× 879 0.9× 51 0.2× 250 1.4× 40 0.8× 107 1.5k
Stavros Dimitrakos Greece 21 814 0.6× 597 0.6× 136 0.7× 134 0.7× 89 1.7× 65 1.0k
Iván J. Suñer United States 19 1.8k 1.3× 1.1k 1.1× 149 0.7× 354 1.9× 41 0.8× 36 2.0k
Adriano Carnevali Italy 28 1.9k 1.4× 1.6k 1.6× 80 0.4× 244 1.3× 118 2.2× 102 2.3k
Aude Couturier France 19 1.5k 1.1× 1.3k 1.3× 61 0.3× 185 1.0× 112 2.1× 78 1.8k
Valentín Huerva Spain 18 655 0.5× 397 0.4× 149 0.7× 128 0.7× 23 0.4× 69 955
Ellen C. La Heij Netherlands 25 1.3k 1.0× 1.1k 1.1× 61 0.3× 230 1.3× 191 3.6× 51 1.5k
Brian C. Joondeph United States 20 1.1k 0.8× 618 0.6× 58 0.3× 266 1.5× 112 2.1× 55 1.3k
Levent Akduman United States 18 791 0.6× 463 0.5× 60 0.3× 130 0.7× 57 1.1× 83 933

Countries citing papers authored by Sanjeewa Wickremasinghe

Since Specialization
Citations

This map shows the geographic impact of Sanjeewa Wickremasinghe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sanjeewa Wickremasinghe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sanjeewa Wickremasinghe more than expected).

Fields of papers citing papers by Sanjeewa Wickremasinghe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sanjeewa Wickremasinghe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sanjeewa Wickremasinghe. The network helps show where Sanjeewa Wickremasinghe may publish in the future.

Co-authorship network of co-authors of Sanjeewa Wickremasinghe

This figure shows the co-authorship network connecting the top 25 collaborators of Sanjeewa Wickremasinghe. A scholar is included among the top collaborators of Sanjeewa Wickremasinghe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sanjeewa Wickremasinghe. Sanjeewa Wickremasinghe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sanfilippo, Paul G., et al.. (2025). Intravitreal Ranibizumab Injections Significantly Influence Retinal Venous Calibre in Patients With Diabetic Macular Oedema. Journal of Ophthalmology. 2025(1). 5637071–5637071.
2.
Tran, Tuan, et al.. (2024). Elevated aqueous TNF‐α levels are associated with more severe functional and anatomic findings in eyes with diabetic macular oedema. Clinical and Experimental Ophthalmology. 52(9). 981–990. 3 indexed citations
3.
Cornish, Elisa E., Sanjeewa Wickremasinghe, Hemal Mehta, et al.. (2023). Aflibercept monotherapy versus aflibercept with targeted retinal laser to peripheral retinal ischemia for diabetic macular oedema (LADAMO). Eye. 37(16). 3417–3422. 2 indexed citations
4.
Wong, James, Andrew Chang, Robyn H. Guymer, et al.. (2021). Phase 1 Study of an Intravitreal Axitinib Hydrogel-based Implant for the Treatment of Neovascular Age-Related Macular Degeneration (nAMD). Investigative Ophthalmology & Visual Science. 62(8). 218–218. 11 indexed citations
5.
Cornish, Elisa E., Kelvin Yi Chong Teo, Mark C. Gillies, et al.. (2021). Five-year outcomes of eyes initially enrolled in the 2-year BEVORDEX trial of bevacizumab or dexamethasone implants for diabetic macular oedema. British Journal of Ophthalmology. 107(1). 79–83. 7 indexed citations
6.
Constantinou, Marios, Sophie Rogers, Sukhpal S. Sandhu, et al.. (2019). Prospective randomised clinical trial of intravitreal bevacizumab versus triamcinolone in eyes with diabetic macular oedema undergoing cataract surgery: 6-month results. British Journal of Ophthalmology. 103(12). bjophthalmol–2018. 12 indexed citations
7.
Lim, Lyndell L., Marios Constantinou, Sophie Rogers, et al.. (2018). The DiMECat Trial: A Prospective, Randomised Clinical Trial Of Intravitreous Bevacizumab vs. Triamcinolone In Patients With Diabetic Macular Oedema At The Time Of Cataract Surgery – 6 Month Results. Investigative Ophthalmology & Visual Science. 59(9). 1958–1958. 2 indexed citations
8.
Wickremasinghe, Sanjeewa, Esther Bandala‐Sanchez, Maria Kolic, et al.. (2018). The Influence of Intravitreal Ranibizumab on Aqueous Cytokine Concentrations in Diabetic Macular Edema. Investigative Ophthalmology & Visual Science. 59(9). 4839–4839. 1 indexed citations
9.
Wickremasinghe, Sanjeewa, et al.. (2017). Retinal vascular calibre changes after intravitreal bevacizumab or dexamethasone implant treatment for diabetic macular oedema. British Journal of Ophthalmology. 101(10). 1329–1333. 12 indexed citations
10.
11.
Wickremasinghe, Sanjeewa, Jing Xie, Devinder S. Chauhan, et al.. (2012). Delay to Treatment and Visual Outcomes in Patients Treated With Anti-Vascular Endothelial Growth Factor for Age-Related Macular Degeneration. American Journal of Ophthalmology. 153(4). 678–686.e2. 97 indexed citations
12.
Wickremasinghe, Sanjeewa, Jing Xie, Robyn H. Guymer, et al.. (2012). Retinal vascular changes following intravitreal ranibizumab injections for neovascular AMD over a 1-year period. Eye. 26(7). 958–966. 8 indexed citations
13.
Wickremasinghe, Sanjeewa, Jing Xie, Devinder S. Chauhan, et al.. (2011). Variants in theAPOEGene Are Associated with Improved Outcome after Anti-VEGF Treatment for Neovascular AMD. Investigative Ophthalmology & Visual Science. 52(7). 4072–4072. 51 indexed citations
14.
Wickremasinghe, Sanjeewa, Elvis Ojaimi, Lyndell L. Lim, et al.. (2010). Intravitreal Methotrexate as Adjunctive, Palliative Therapy in Intraocular T-cell Lymphoma. Ocular Immunology and Inflammation. 18(3). 184–186. 9 indexed citations
15.
Michalová, K, Sanjeewa Wickremasinghe, Andrew Chang, et al.. (2009). Ranibizumab treatment for neovascular age-related macular degeneration: from randomized trials to clinical practice. Eye. 23(8). 1633–1640. 15 indexed citations
16.
Wickremasinghe, Sanjeewa, K Michalová, Jagjit S. Gilhotra, et al.. (2008). Acute Intraocular Inflammation after Intravitreous Injections of Bevacizumab for Treatment of Neovascular Age-related Macular Degeneration. Ophthalmology. 115(11). 1911–1915.e1. 104 indexed citations
17.
Wickremasinghe, Sanjeewa, et al.. (2008). WOUND LEAK AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB. Retinal Cases & Brief Reports. 2(3). 245–246. 3 indexed citations
18.
Wickremasinghe, Sanjeewa, et al.. (2005). Cross-sectional differences in axial length of young adults living in urban and rural communities in Mongolia. LSHTM Research Online (London School of Hygiene and Tropical Medicine). 3 indexed citations
19.
Tranos, Paris, Sanjeewa Wickremasinghe, Neil Sinclair, et al.. (2003). Visual perception during phacoemulsification cataract surgery under topical and regional anaesthesia. Acta Ophthalmologica Scandinavica. 81(2). 118–122. 32 indexed citations
20.
Tranos, Paris, et al.. (2002). Pseudohypopyon as a Feature of Multiple Myeloma. Archives of Ophthalmology. 120(1). 87–87. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alex P. Hunyor Breakdown of academic impact, for papers by Manuel Falcão Breakdown of academic impact, for papers by Stavros Dimitrakos Breakdown of academic impact, for papers by Iván J. Suñer Breakdown of academic impact, for papers by Adriano Carnevali Breakdown of academic impact, for papers by Aude Couturier Breakdown of academic impact, for papers by Valentín Huerva Breakdown of academic impact, for papers by Ellen C. La Heij Breakdown of academic impact, for papers by Brian C. Joondeph Breakdown of academic impact, for papers by Levent Akduman
Rankless by CCL
2026